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Abstract  
There is evidence of a small but significant proportion of adolescents engaging in 
doping practices. Young athletes face very specific pressures to achieve results as 
they strive for a career at an elite level. This study employed an anonymised 
questionnaire to survey 403 (12-21 years old) talented young athletes’ attitudes 
toward performance enhancing substances and supplements. Two thirds of the 
sample was male. Athletes were generally against the use of doping substances to 
enhance sporting performance. Within this generally unfavourable view, males 
tended to express a more permissive attitude toward performance enhancing 
methods than females. Those convinced of the necessity of supplementation for 
sporting success were also more likely to express permissive attitudes. When asked 
whether they would take a ‘magic’ drug that, whilst undetectable would significantly 
enhance performance, the overwhelming majority of athletes said ‘no’, but many 
thought others would take the substance. Interestingly there was a significant 
association between the projected use of the hypothetical drug by competitors, and 
the individual respondent’s willingness to take the hypothetically ‘magic’ substance. 
The study offers an insight into young athletes’ attitudes toward specific forms of 
performance enhancement, and the strength of their beliefs in the face of a tempting 
hypothetical scenario.  
 
Keywords: performance enhancing substances; anti-doping; doping; enhanced 
appearance.
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Introduction 
The use of substances to enhance sporting performance is not a new phenomenon. 
Doping substances in cycling, for example extra caffeine, cocaine and strychnine, 
were used as far back as the 1890s and were not banned for the first sixty years of 
the Tour (Hoberman, 2004). Generalised anti-doping legislation, however, appeared 
much later. One watershed was the 1965 anti-doping law passed by the Belgian and 
French Senate (April and June respectively), and the subsequent establishment of 
the International Olympic Committee Medical Commission. These are thought to 
have arisen from deaths in sport associated with substance use (Becket and Cowan, 
1979). More recently the Tour de France of 1998 provided evidence of a systemic 
doping problem in the sport. The World Anti-Doping Agency (WADA) was established 
in 1999, providing a centralised body that aimed to harmonize anti-doping strategies 
across elite sports (Catlin et al. 2008).  
 
According to one widely used official definition, a doping offence occurs when 
athletes ‘use prohibited substances or methods to unfairly improve their sporting 
performance’ (UK Sport, 2009). In this paper 'Supplement' refers to an overarching 
name for vitamins, minerals, herbal remedies and other substances (creatine and 
protein powders, for example). Supplements, by definition, are not subject to anti-
doping regulations. The precise articulation of which substances and methods ought 
to be prohibited has been a hotly contested affair1. WADA’s World Anti-Doping Code 
(WADC) considers whether or not to ban a substance on the basis of its fulfilling two 
of the following three criteria: that it (i) enhances or has the potential to enhance 
performance (ii) threatens health or has the potential to do so; and (iii) is ‘contrary to 
                                                 
1
 For a debate over the legitimacy of hypoxic air machines see Spriggs (2005) and related 
commentaries (Tännsjö, 2005; Tamburrini, 2005 and Fricker, 2005). While the debate concerns one 
method in particular, the questions it raises concern enhancement and technology in sport more 
generally. 
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the spirit of sport’ (WADA, 2009: 33); or by acting as a masking agent in relation to a 
prohibited substance. 
 
The extent to which banned substances are being utilised by elite athletes is difficult 
to determine. The number of athletes reported as testing positive by anti-doping 
bodies is small, often around 2% (WADA 2002-2008). Estimates of prevalence 
derived from athlete surveys, as opposed to actual test results however, have 
occasionally been as high as 20% (see Pistch et al., 2005).2 While the actual extent 
of doping in sport is disputed, WADA’s requirement that athletes be available for 
randomised testing throughout the year provides an indication of the perceived 
pervasiveness of the problem. 
 
The issue of doping is generating interest from researchers and policymakers alike. 
This interest stems not only from the concerns over the spirit of sport and the health 
of athletes illustrated by the WADA, but also from evidence of a spread beyond the 
athlete population. While Anabolic Androgenic Steroids (AAS) are the substances 
causing adverse analytical findings among high performing athletes (WADA 2002-
2008), use of such substances by those outside of sport is generating increasing 
public health concerns (Kanayama et al., 2008).  
 
There is also evidence of doping substances being used by young people. One study 
found evidence of AAS use among high school (American) footballers starting before 
the age of ten (Stilger and Yesalis, 1999; although mean age for starting AAS use in 
                                                 
2
 This study with German athletes employed a randomised response technique comprised of one 
question, basically have you ever used doping substances? (Or a variation such as have you in this 
season?), with an additional instruction. The additional instruction required athletes born in the months 
January to April to answer yes, and those born in other months to answer honestly. Thus even the 
researchers could not judge whether the individual athlete had taken performance enhancing drugs in 
this online survey, but calculated prevalence figures from the ‘yes’ and ‘no’ responses, and data 
concerning the frequency of births from January to April. 
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this population was 14). Review studies (albeit predominantly North American) 
suggest between 3 and 12 % of adolescent males (Yesalis and Bahrke, 2000; Calfee 
and Fadale, 2006) have reported using AAS at some point. Use by females is 
reported to be lower, around 1-2% admitting using steroids (Yesalis and Bahrke, 
2000). Again, these data are not confined to participants in competitive sports. Of 
adolescents who reported using AAS, review articles suggest between 30 and 40 per 
cent were not engaged in competitive sport (Bahrke, et al., 2000; Calfee and Fadale, 
2006). Among non-sporting motivations, the desire to increase muscle mass to 
enhance physical appearance is a dominant one (see for example Field et al., 2005). 
 
With regard to adolescent and child populations, it seems we know little generally 
about the effect of these substances. Unsurprisingly there is little to no research on 
the effects of these substances in the young (Gregory and Fitch, 2007). The 
American Academy of Pediatrics (2005) state that ‘Virtually no experimental research 
on either the ergogenic effects or adverse effects of performance enhancing 
substances has been conducted in subjects younger than 18 years.’ (American 
Academy of Pediatrics, 2005: 1104). McNamee (2009) also recognises that the 
harms of such substances in adolescents are relatively unknown. This is cited as a 
significant difference to other medical procedures to which a minor may be judged to 
offer informed consent, where the potential harms are better understood. Thus, any 
suggestion that adolescents could be deemed competent to consent to doping, as 





                                                 
3
 Thus in the UK, the well known notion of Gillick Consent, where a child may reasonably 
request or refuse treatment if they can reasonably understand the intervention, its harms and 
benefits, cannot apply.  
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This large scale survey was conducted to address athletes’ attitudes toward doping 
and supplementation. ‘Attitudes’ in this context should be understood as athletes’ 
positive or negative evaluations (Schwartz and Bohner, 2001) of the different 
methods, or possible methods utilised to enhance performance. There is little 
research concerning young athletes’ attitudes toward doping. Yet critics have noted 
that the zero-tolerance attitudes of anti-doping authorities in sport is at odds with 
apparent acquiescence towards drug usage elsewhere in society (Kayser and Smith, 
2008; Laure, 2009). This study sought to probe the extent to which talented young 
British athletes have endorsed the anti-doping message. Thus the study has the 
potential to assess the effectiveness of anti-doping educational campaigns. More 
generally it also provides an insight into athletes’ responses to the pressures they 
face. Effective anti-doping efforts, and educational programmes arising from them, 
must be informed by athletes’ attitudes toward performance enhancing substances.  
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Materials and methods 
 
Sample 
The study sought to assess the attitudes of talented young athletes. Athletes in the 
UK may receive support, or funding of some kind, if they are deemed to have 
reached a designated level of expertise or have high potential expertise.  Here 
‘talented’ denotes athletes receiving support from the ‘Talented Athlete Scholarship 
Scheme’ (providing services to those athletes in further or higher education); UK 
Sport’s own ‘World Class Pathways’, where funding levels correspond to anticipated 
success at major international competitions, with particular reference to the Olympic 
Games; and to those athletes recruited via the national Academy structures (Cricket 
and Rugby Union); and via the Professional Footballers Association 
(Football/Soccer). In total 1674 Talented athletes (age range 12-21) were identified 
via these means. 403 of 412 questionnaires returned were within the age range 
required.  The aim was to cover the largest possible range of Olympic and 
professional sports. (See Table 1 for a breakdown of the sample by sport).  
 
INSERT TABLE 1 HERE  
 
Most of the questionnaires were distributed direct to the athlete’s home address by 
mail, advising that completed responses should be returned to the research team. 
Addresses were provided by the research contractor UK Sport, having sought the 
permission of appropriate clubs, governing and funding bodies. One exception 
involved questionnaires being distributed by the governing body (again in hard copy 
by mail, with returns made to the research team). In addition to these means, 
additional efforts were made to increase the participation rate. Researchers utilized 
their own contacts at clubs to facilitate distribution of the questionnaire. Researchers 
were always careful however, to ensure that athletes were fully aware that their 
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responses would remain anonymous, and would not be disclosed to clubs, governing 
bodies or the research contractor UK Sport. The response rate was disappointing 
(see Table 2), but perhaps unsurprising bearing in mind this population is necessarily 
focused on goals concerning performance enhancement, and likely to be reluctant to 
involve themselves in additional projects without such an aim. 
 
INSERT TABLE 2 HERE 
 
Over two-thirds of the athletes were between age 16 and 19 (16.4%, 18.1%, 16.4% 
and 16.1%, respectively), followed closely by age 20 (12.2%). The remaining age 
categories (by years) contributed less than 8% each. Two thirds of the sample were 
male. 
 
Within the sample 23.6% of athletes were identified as ‘world class development 
athletes’ (from UK Sport’s ‘World Class Pathways’). Just over half of the sample 
comprised athletes from Olympic sports while nearly one half were players from non-
Olympic sports or Paralympic athletes. (Athletes from Paralympic sports comprised 
2.8% of the sample). The majority of the sample had experience of competition at an 
international level. 
 
INSERT FIGURE 1 HERE  
 
The sample was predominantly (94%) of ‘white’ ethnicity. Athletes had considerable 
assisted sport experience with 34.5% training ≥5 years, 31.8% training ≥9 years and 
a further 11.4% training ≥12 years with a coach.  The percentages are cumulative for 
the lowest category (i.e. 77.7% of the participants received coaching for at least or 
more than 5 years). 
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Measures 
Athletes completed a modified version of a questionnaire used by UK Sport in its 
2005 Drug-Free Sport survey. After piloting, the questionnaire was simplified, in light 
of the target population (aged 12-21 years). Further modifications included the 
addition of a set of questions related to the athletes’ bodily perception, adapted from 
a Norwegian study (see Breivik et al., 2009). Research questions were related to 
beliefs about the necessity of supplementation, and supplement use. Questions also 
addressed body satisfaction, body modification and perceived willingness of 
competitors to take prohibited performance enhancing substances. While athletes 
were asked whether they would take a hypothetical substance that guaranteed 
success, they were not asked directly whether they had used, or were using doping 
products. The study was aimed at exploring doping attitudes, rather than behaviour. 
The specific questions addressed in this analysis are stated in the results section.  
 
Analyses 
Data characteristics were shown as frequencies, percentages and means with 
standard deviations. Scale reliability was assessed by Cronbach alpha coefficient. 
Group differences we calculated using t-test and ANOVA with Tukey post hoc test. 
Relationships were tested by using nonparametric correlation, whereas contingency 
tables were used for calculating the odd ratios. Statistical analyses, including 
descriptive statistics, were performed using SPSS 16.0. 
 
Ethical Approval 
Ethical procedures followed established practices (Jago and Bailey, 2001; McNamee 
et al., 2006). Ethical approval was granted by the Research Ethics Committee of the 
School of Health Science, Swansea University. The questionnaire was distributed 
toward the end of 2006 and beginning of 2007. Consent forms were completed by all 
participants (and parents/guardians where appropriate), the forms and project 
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information sheets having been distributed with the questionnaire. In particular 





In response to the question ‘How much do you agree or disagree with the following 
statement: “You have to take supplements to be successful in sport”?’ the majority of 
the young athletes disagreed (45.4%) or strongly disagreed (33.0%).  Those who 
thought otherwise were the older (age 17-20) athletes with ≥5 years of coached 
athletic career.  Fifteen percent of the respondents (males: 18%, females: 10%) 
agreed with the notion that supplement use is necessary to be successful in sport.   
 
Athletes were asked ‘Which of the following do you believe should be allowed in your 
sport?’ and were provided with seven statements regarding methods for various 
performance enhancing reasons. (Altitude Chamber to improve your endurance; Any 
substances which will improve your endurance; Any substances which will increase 
the amount of training you can do; Any substances which will increase your strength; 
Any substances which will increase your ability to cope with pain; Any substances 
which will improve your concentration; Any method to alter your genes which will 
enhance your performance).  The respondents expressed a strong belief that no 
substance should be allowed for performance enhancing purposes. Among the data, 
the use of any substance to improve concentration was the most acceptable, while 
gene manipulation was the least (Table 3).  One notable exception was the use of 
hypoxic rooms, of which use was endorsed by many athletes (Figure 2). 
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Upon further investigation using principal component analysis with Varimax rotation 
(KMO = .779, Bartlett’s test of sphericity = .563.55, p < .001), six of the seven 
questions formed a scale that we named as ‘Performance Enhancements Belief 
Scale (PEBS)’. Response options that followed each statements were presented on 
a three-point scale and anchored as 2 = should be allowed, 1= within reason or 0 = 
should not be allowed. One additional question ‘Altitude chamber, to improve your 
endurance’ in the survey did not contribute to the PEBS having below the acceptable 
factor loading (-.297). Other item loadings were, in decreasing order: increase 
strength = .798, increase endurance = .796, increase the amount of training = .738, 
enhance concentration = .685, help coping with pain = .498, altering genes = .464. 
Reliability coefficient of the six-item scale was  = 0.748.  
 
INSERT TABLE 3 HERE  
INSERT FIGURE 2 HERE  
 
Within a generally unfavorable view, male athletes (M = 2.136  3.05) expressed a 
more liberal attitude toward the use of different performance-enhancing methods 
than females (M = 1.088  1.976). The difference was statistically significant (t = -
3.484, p = 0.001). This more liberal attitude was expressed by those who also 
believed that supplementation is necessary for sport success. Using agreement level 
as grouping variable, we created five independent groups (Table 4). A statistically 
significant overall difference (F = 5.216, p < 0.001) and between group differences for 
strongly disagree – disagree (p = 0.045) and strongly disagree – agree (p = 0.003) 
pairs. In other word, those who felt strongly about not needing nutritional 
supplements for achieving success scored the lowest on the PEBS indicating that 
using any substances for any performance enhancing reasons is not acceptable.  
This strong opposition differentiated this group of young athletes (N = 130) from the 
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rest, with two differences reaching statistical significance. The differences were in the 
expected direction: those who agreed or strongly agreed with the necessity of 
nutritional supplements scores above both the theoretical (= 2.5) and the sample (= 
1.75) mean for this question. Means and standard deviations are displayed in Table 
4. 
 
INSERT TABLE 4 HERE    
 
Athletes were also asked ‘Which of the following (if any) describe why you take a 
supplement or supplements?’. Among the selectable options, avoiding sickness, 
maintaining strength, enhancing endurance, dealing with imbalanced diet, aiding 
recovery from illness, training longer, overcoming injury and lack of sleep were 
specified; followed by an option to indicate other reason(s) or not knowing the 
reason. The belief about the necessity of using of supplements to be successful 
recorded the highest association ( = 0.213, p < 0.001) with augment strength as a 
reason for supplement use. This may be the effect of the dominantly male sample. 
The relationship was non-significant for females ( = 0.090, p = 0.293) and stronger 
for males ( = 0.242, p < 0.001) when we analysed separately. 
 
In questions when hypothetical situations regarding using prohibited substances or 
methods were presented, athletes were asked to indicate their own willingness to 
take the substance or method, and estimate the likelihood of other athletes’ doing the 
same. The scenario was presented as this: ‘Imagine that there is a prohibited 
(banned) substance or method that would significantly enhance your performance 
but was completely undetectable.  How many of your fellow competitors do you think 
would take it? (All of them; probably most of them; probably some of them; definitely 
none of them; don’t know). Would you take it? (Yes definitely; probably; probably not; 
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no, definitely not; don’t know). The two conditions were: i) not having serious health 
consequences and ii) shortened life span.  
 
When athletes were asked whether they would take the ‘magic’ drug, less than 10% 
answered affirmatively. When asked whether they would take the drug while causing 
a shortened lifespan of 10 years, the willingness to take the drug fell below 1%. 
Differences between male and female responses to this question were observed. 
With no harm stipulated (2 = 17.732, p = .001) more males indicated willingness to 
use a prohibited substance if it would be undetectable (3/259 yes and 22/259 
probably) than females (0 yes and 3/133 probably).  The majority of the athletes 
(130/133 females and 235/259 males) said that they would not use the hypothetical 
substance if it would reduce lifespan. Only 1 male said yes and further 3 said 
probably under this condition. Female athletes categorically refused the option to 
take the life-span reducing prohibited substance, regardless of its performance 
enhancing effect. 
 
There was an observable pattern showing that those with more years ‘invested’ in 
their athletic career may be more willing to take the undetectable but banned 
performance enhancing substance (with no harm) but no statistically significant 
association was found between years in training and willingness (2 = 25.854, p = 
.171).  The pattern reached significance under the scenario that the substance would 
reduce lifespan (2 = 27.086, p = .028).  As indicated above, however, the number of 
athletes expressing willingness under this condition was extremely low. 
 
Despite athletes’ self-reported behavioural intention (or lack of) in these hypothetical 
situations, there was a dramatic increase in the proportion of athletes (72.6%) who 
believed that at least some other athletes would take the drug if it produced no 
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harmful effects. Even assuming shortened life-span, more than 40% believed that at 
least some athletes would take the drug. Detailed frequency counts are presented in 
Table 5.   
 
To calculate odd ratios between projected use and behavioural intention in these 
hypothetical situations, we grouped answers into two main categories: Yes and No 
(see Table 5).  In the ‘no health risk’ scenario, there was a statistically significant 
association between projected use and behavioural intention (2 = 6.571, p = 0.01). 
Odd ratios and risk for those who indicated self-use in the absence use by others 
cannot be calculated (the cell had zero frequency).  In the ‘shortened life span’ 
scenario, the association was less significant (2 = 0.898, p = 0.343). The results 
indicate that there is a 2.8 times higher risk of using banned performance 
enhancement if the use in others is assumed. However, in both scenarios, cells 
contained frequencies < 5, hence interpretation of the results should only be made 
cautiously. 
 
INSERT TABLE 5 HERE  
 
Assuming that there may be a common psychological basis to appearance 
enhancement and performance enhancement, we asked young athletes ‘How happy 
are you with the appearance of your body? Most young athletes indicated that they 
were happy with their appearance. Notably, more male (93.4%) than females 
(80.5%) said that they were quite happy or happy with the way they look. The issue 
of body satisfaction was further probed by asking if they would i) take a substance 
that give them a more muscular body; ii) go on a very low calorie diet to lose weight; 
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iii) go on a very high calorie diet to gain weight; and iv) have a tattoo somewhere on 
their body and v) undertake plastic surgery to change appearance.4 
 
As expected, willingness to change appearance by some means (i.e. taking 
substances for a more muscular body, drastic diet to lose or gain weight, having a 
tattoo or plastic surgery) was inversely related to the satisfaction with correlation 
coefficients (Kendall tau []) as follows: -0.012 (p = 0.005), -0.239 (p < 0.001), 0.008 
(p = 0.865), -0.047 (p = 0.291) and -0.158 (p = 0.001), respectively. Satisfaction with 
appearance appears to be independent of the belief regarding using substances to 
achieve a specific goal (listed in Table 3, (Kendall tau [] = -.019, p = .677 for the 
overall belief [PEBS] with none of correlation with the individual elements reaching 
|0.1|). On the contrary, there was small but significant positive relationship between 
the belief whether supplement use is necessary to be successful in sport and 
expressed willingness to use substances for a more muscular body ( = 0.227, p < 
0.001) and employ a drastic diet to gain weight ( = 0.121, p = 0.006). 
 
Discussion 
Athletes generally expressed strong attitudes against the use of performance 
enhancing substances in sport. This is, of course, unsurprising. First, we should 
acknowledge the highly stigmatised nature of doping in sport, and the possibility that 
these responses are those thought socially desirable by the athletes, even where 
anonymity is assured. In light of the low response rate there is also a possibility of 
self-selection, athletes with more permissive attitudes toward doping being unwilling 
to return the questionnaire. It is just as feasible, however, that this necessarily 
                                                 
4
 Questions regarding body satisfaction and appearance were adapted from an existing 
Norwegian survey (see Breivik et al. 2009). 
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narrowly focused population are not generally pre-disposed to research with no clear 
performance enhancement benefits.  Scepticism concerning the reliability of the 
responses should not be exaggerated. Literature suggests that adolescent doping is 
generally not widespread, but confined to a minority. Laure et al.’s (2004) survey of 
French high school athletes found similar anti-doping responses, with over 90% of 
athletes stating that doping was against the spirit of sport (94%) and dangerous for 
health (93%). The methodology employed, however, also garnered some less 
socially desirable responses: 22% of athletes concluding that refusing to dope 
relinquished all chances of sporting success while 4% of these athletes admitted to 
having used doping agents. Laure et al. (2004) employed a questionnaire, and as in 
this study, assured athletes of the anonymity and confidentiality of responses.  
 
Within the generally anti-doping posture, males expressed more permissive attitudes 
toward the use of performance enhancing drugs than females. Alaranta et al.’s 
(2006) study of elite Finnish athletes provides further evidence that male athletes 
remain more at risk of doping in the sporting domain. They report that 35% of males 
and 23% of females stated that they personally knew an athlete doping. Alaranta et 
al.’s study, one of few that explores doping-attitudes, provides further evidence of a 
gender difference in observing that more men would use substances than females 
(9.2% vs. 7.3%) in the event of their legalisation. Prevalence data has also 
suggested that the use of AAS is greater in males. Kanayama et al. (2007) concur 
with this but argue that prevalence studies using self-report questionnaires typically 
over report usage. They question the methodology of questionnaires, suggesting 
survey questions may have elicited false positive responses.  While there may be 
legitimate questions over the accuracy of prevalence reports, our finding that males 
are more likely to express permissive attitudes toward performance enhancing 
substances appears to retain international support.  
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Studies have suggested that those who use supplements (often focusing on 
supplements deemed ‘performance enhancing’ and used for muscle and strength 
building such as protein, amino acids and creatine) are also more likely to engage in 
doping practices (see Dodge and Jaccard, 2006; Lucidi et al., 2008; Papadopoulos et 
al., 2006). In this study those convinced of the necessity of supplementation for 
sporting success (often older athletes with greater length of coached career) were 
more likely to express permissive beliefs regarding performance enhancing 
substances. Thus a minority of the sample were sure of the benefits of supplements 
and this attitude can be associated with a more permissive attitude toward 
enhancement more generally. One would expect such an association. Athletes with 
more favourable attitudes toward doping would also be likely to consider legal forms 
of supplementation and enhancement. This research, in common with the studies 
above, does not establish causality. Thus further research is required to establish 
whether supplement use, and corresponding perceptions of their benefits precede 
more permissive attitudes toward doping and ultimately doping behaviour. 
 
Athletes were generally unwilling to take a ‘magic’ undetectable drug that would 
significantly improve performance. This finding suggests that the athletes were not 
merely concerned about the potential sanctions associated with doping, but may also 
be motivated not to dope by ethical reasons.  This explanation is supported by the 
findings of Strelan and Boeckmann (2006) who found that athletes refrain from 
doping for moral and health reasons, not for the fear of getting caught. This is no 
doubt encouraging to organizations that are responsible for the education of young 
athletes in relation to anti-doping attitudes. Yet such results should be interpreted 
with caution. This direct, albeit hypothetical line of questioning, may have elicited 
socially desirable responses, those the athletes thought researchers and indeed the 
research contractor expected to hear. 
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This question was a modified version of Goldman’s (1984) frequently cited survey of 
American world class athletes (weightlifters and competitors in field athletics). 
Athletes were asked if they would take a magic drug that would guarantee success 
(winning every competition) for the next five years, but would cause death five years 
after it had been taken.5 Goldman reports that 52 per cent (103/198) of the athletes 
asked stated that they would take the drug. This is certainly a much stronger 
response, although Goldman offered a guarantee of success rather than the mere 
significant enhancement suggested in this survey. Goldman also claims athletes 
were not deterred by the possibility of death in five years. The present sample 
expressed a considerably more conservative view.  Participants were much more 
concerned with any reduction in life span. Less than 1% responded positively under 
this scenario. The picture of an athlete as a ruthless, single-minded individual, with 
little concern for the future, perhaps fuelled by the Goldman responses, does not fit 
with this more cautious, group of athletes.  
 
It is worth noting the paradox that while elite sport is often advocated and marketed 
in health promoting contexts, it is scarcely conducive to good health (Howe, 2004, 
Møller, 2008).  Elite sportspersons live on the boundaries of illness and injury in their 
pursuit of perfection. Yet this did not inform the responses of most athletes in relation 
to the second hypothetical scenario. This may be attributable either to the crudeness 
of the life-span reduction question itself, or their negative perceptions of the use of 
performance enhancing substances, whether banned or permitted. Further research 
should investigate how athletes differentiate between different harms to health. In 
subsequent focus groups conducted as a following phase to this study, some 
                                                 
5
 Goldman’s findings regarding these questions are included in his book Death in the Locker 
Room, (Goldman, Bush and Klatz 1984). They are the results of polls Goldman himself 
conducted.  
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athletes expressed concern at the ‘unknown’ effects of doping, and felt they were 
better able to manage any risks associated with their sport. 
 
Less encouraging for anti-doping authorities and educators, was the proportion of 
athletes (72.6% no reduction in life span, 40% reduction in life span by ten years) 
who believed that other athletes would take the ‘magic’ drug. Projected figures are 
difficult to interpret. First, the response does not provide any greater specificity, the 
majority of athletes thought that ‘probably some’ would take the drug, and indeed the 
‘probably some’ was one response up from ‘none of them’ with the other remaining 
options, ‘all of them’ ‘probably most of them’ and ‘don’t know’. Secondly, projected 
figures often provide higher estimates than answering on one’s own behalf. In a 
Norwegian study utilizing a similar scenario (Gilberg et al., 2006), 10% of young 
athletes thought others would dope, whereas only 1% said they would take the 
undetectable substance themselves.  
 
Although we should urge caution in the interpretation of these particular results, a 2.8 
times higher risk of intending to use the hypothetical banned substance was found if 
use in others was assumed. One possible interpretation of this relationship between 
projected use in others and intention to use in the hypothetical magic drug scenario 
may be explained by the phenomenon called ‘false consensus effect’. It has been 
shown in a doping context that projected use estimation is likely to reflect self 
behavior. Petróczi et al., (2008) report that those athletes who admitted using 
performance enhancing substances significantly overestimated the same behavior in 
others compared to those who were reportedly absent from doping use. The results 
were repeated among Hungarian competitive athletes (Uvacsek et al. 2009), with 
further evidence that the estimation is domain specific. Those who used doping 
products and processes gave high estimations of doping use among other athletes 
but not for the use of social drugs, and vice versa. An equally possible explanation is 
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that projected use may act as a descriptive norm. If athletes believe that a high 
proportion of the fellow athletes and competitors are engaged in doping practices, not 
wanting to be disadvantaged, this belief could lead to the use of similar means. 
 
The relationship found between body satisfaction and believing that it is necessary to 
use performance enhancing substances (typically males) or engage in body 
modification is in line with the recent findings of Breivik et al. (2009). A survey 
conducted among Norwegian athletes and general population found that body 
satisfaction correlated significantly and positively with enhancements (i.e. the 
acceptance of using substances to increase physical strength, endurance and sexual 
ability) whereas negative correlation was found with physical invasion such as 
corrective surgery (liposuction, stomach clamping) and having a tattoo.  
 
Perspectives 
This study sought to assess the extent to which young athletes have ‘bought into’ the 
anti-doping message. Athletes were generally against substances and methods to 
enhance performance. Many athletes, however, believed that others would take a 
hypothetical, undetectable drug that would significantly enhance performance. 
Results indicated a significant association between this projected use and the 
individual’s own behavioural intention to use the substance in this scenario. There is 
further support for such an association (see Petróczi et al., 2008 and Uvacsek et al. 
2009). This phenomenon, and whether it acts as a descriptive norm or is used as 
retrospective justification, requires further investigation. The decision to dope may be 
influenced by the perceived behaviour of friends and competitors. Papadopoulos et 
al. (2006) found that tertiary education students whose friends doped were greater 
than seven times more likely to have used doping products at least once themselves. 
Research examining the doping decision, and athletes’ attitudes, must acknowledge 
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these other influences. While all such studies must recognise the possibility of 
socially desirable responses, sensitively designed studies that seek to rectify the 
present dearth of research on athletes’ attitudes toward doping have the potential to 
enhance the efficacy of anti-doping education programmes. 
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Table 1: Sample characteristics by sports 
 
Sports N (%)  Sports N (%) 
Athletics 19 (4.7)  Rugby league 1 (0.2) 
Badminton 4 (1.0)  Rugby union 112 (27.8) 
Boxing 4 (1.0)  Sailing 2 (0.5) 
Canoeing 6 (1.5)  Skiing 3 (0.7) 
Cricket 17 (4.2)  Snowboarding 1 (0.2) 
Curling 3 (0.7)  Squash 3 (0.7) 
Cycling 19 (4.7)  Swimming 27 (6.7) 
Diving 8 (2.0)  Synchronised 
swimming 
9 (2.2) 
Equestrian 11 (2.7)  Table tennis 14 (3.5) 
Fencing 10 (2.5)  Taekwondo 5 (1.2) 
Football 56 (13.9)  Tennis 5 (1.2) 
Golf 5 (1.2)  Water-polo 7 (1.7) 
Hockey 4 (1.0)  Waterskiing 3 (0.7) 
Judo 5 (1.2)  Wrestling 2 (0.5) 
Modern 
pentathlon 
3 (0.7)  Other 4 (1.0) 
Netball 4 (1.0)     
Orienteering 5 (1.2)  Wheelchair 
rugby 
3 (0.7) 
Powerlifting 2 (0.5)  Wheelchair 
basketball 
3 (0.7) 
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Table 2: Response rates 








TASS 483 138 29 135 
WCDA 234 101 43 95 
NGB athletes 957 173 18 173 
Total 1674 412 25 403 
 
TASS = Talented athlete scholarship scheme; WCDA = World Class Development 
Athletes; NGB athletes = players recruited via national governing bodies in football, 
rugby union and cricket 
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Table 3: Items, answer frequencies and item mean scores of the Performance 









Mean  SD 
Any substances which will 
improve your endurance. 
337 1 48 0.35  0.662 
Any substances which will 
increase the amount of 
training you can do. 
323 1 58 0.31  0.719 
Any substances which will 
increase your strength. 
318 1 66 0.35  0.755 
Any substances which will 
increase your ability to cope 
with pain. 
316 1 67 0.35  0.761 
Any substances which will 
improve your concentration. 
285 1 96 0.51  0.869 
Any method to alter your 
genes which will enhance 
your performance. 
378 0 6 0.03  0.248 
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Table 4. PEBS item means by agreement that supplements need to be taken to 
be successful in sport. 
Groups N PEBS Scale Mean Std. deviation 
Do not know 14 1.5714 3.34467 
Strongly disagree 130 1.0692 2.05426 
Disagree 173 1.9538 2.79496 
Agree 48 2.9167 3.57196 
Strongly agree 4 4.0000 3.65148 
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Table 5: Hypothetical scenarios on using prohibited substance or method 
  No health 
consequence 
Shortened life-span 
 Others frequency % frequency % 
YES All of them 12 3.0 1 0.2 
Probably most of them 51 12.7 6 1.5 
Probably some of them 228 56.6 169 41.9 
NO Definitely none of them 58 14.4 166 41.2 
- I do not know 52 12.9 60 14.9 
      
 Self     
YES Definitely 3 0.7 1 0.2 
Probably 26 6.5 3 0.7 
NO Probably not 95 23.6 24 6.0 
Definitely not 265 65.8 374 93.0 
- I do not know 13 3.2 0 0.0 
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Figure 1: Sample characteristics by the level of sport involvement 
 


















Figure 2: Athletes’ opinions regarding allowing various performance 
enhancing methods in sport, identified by their core function. Scores are mean 
scores with higher score representing a more permissive approach in the 
group (male vs. female athletes). 
 
 
 
